Sunshine Biopharma (SBFM) FCF Margin (2015 - 2026)
Sunshine Biopharma (SBFM) reported FCF Margin of 25.68% for Q1 2026, down 655.0% on a YoY basis from 4.63% in Q1 2025, and down 36.39% quarter-over-quarter from 18.83% in Q4 2025.
Sunshine Biopharma (SBFM) FCF Margin (2015 - 2026) Analysis & Trends
Sunshine Biopharma has reported FCF Margin for 10 years, with the latest figure at 25.68% in Q1 2026.
- For the quarter ending Q1 2026, FCF Margin fell 655.0% year-over-year to 25.68%; the trailing twelve-month figure through Mar 2026 stood at 16.57% (up 1831.0% YoY), and the FY2025 full-year result was 15.16%, up 2550.0% from the prior year.
- FCF Margin for Q1 2026 stood at 25.68%, down from 18.83% in the prior quarter.
- The five-year high for FCF Margin was 7.81% in Q3 2025, with the low at 1063.4% in Q1 2022.
- Historically, FCF Margin has averaged 161.49% across 5 years, with a median of 36.56% in 2024.
- Annual changes were most pronounced in 2022 — FCF Margin plunged 32109 bps — and 2023, when it jumped 102560 bps.
- Sunshine Biopharma's FCF Margin stood at 61.95% in 2022, then jumped by 52 bps to 30.04% in 2023, then dropped by 22 bps to 36.56% in 2024, then surged by 48 bps to 18.83% in 2025, then sank by 36 bps to 25.68% in 2026.
- The last three FCF Margin figures came in at 25.68% (Q1 2026), 18.83% (Q4 2025), and 7.81% (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | -5.22% |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 12.86% |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 46.39% |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 16.78% |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | -2.77% |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -429.96% |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 13.24% |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 32.62% |
| 10 | Sunshine Biopharma | 10.94 Mn | 4.03 Mn | 2.18 Mn | -25.68% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -25.68% |
| Dec 31, 2025 | -18.83% |
| Sep 30, 2025 | -7.81% |
| Jun 30, 2025 | -15.43% |
| Mar 31, 2025 | -19.13% |
| Dec 31, 2024 | -36.56% |
| Sep 30, 2024 | -22.21% |
| Jun 30, 2024 | -59.68% |
| Mar 31, 2024 | -43.07% |
| Dec 31, 2023 | -30.04% |
| Sep 30, 2023 | -7.84% |
| Jun 30, 2023 | -67.94% |
| Mar 31, 2023 | -37.80% |
| Dec 31, 2022 | -61.95% |
| Sep 30, 2022 | -846.14% |
| Jun 30, 2022 | -381.75% |
| Mar 31, 2022 | -1,063.40% |
| Dec 31, 2021 | -366.68% |
| Sep 30, 2021 | -1,192.65% |
| Jun 30, 2021 | -1,170.43% |